Circumventing

Phoenix, Arizona—The state of Arizona has initiated legal action against British pharmaceutical giant GlaxoSmithKline (GSK), accusing the company of maneuvers designed to bypass legislation intended to limit prescription medication costs. This legal challenge emerges amidst concerns surrounding the affordability and accessibility of essential asthma treatments. Filed in Maricopa County Superior Court, the lawsuit alleges that GSK violated the Arizona Consumer Fraud Act and statutes under the Medicaid Prescription Drug Rebate Program. The program, established in the 1990 budget compels pharmaceutical companies to offer financial rebates to the government if their drug prices escalate above inflation … Read more